Tuberous sclerosis complex (TSC) is a genetic disorder characterized by tumor formation in multiple organs, with over 80% of TSC patients developing angiomyolipomas (TSC-AMLs). However, the molecular events that contribute to TSC-AMLs are not well understood. Recent reports have demonstrated that microRNAs (miRNAs) are critical in TSC cortical tubers. However, little is known about the role of miRNAs in TSC-AMLs. In the current study, we analyzed changes in the miRNA and mRNA profiles in TSC-AMLs and matched normal adjacent tissues. A total of 15 differentially expressed miRNAs and 2664 mRNAs were identified. Using quantitative real-time PCR, we confirmed the results of the miRNA and mRNA profile experiments. Through bioinformatic analysis and luciferase reporter assays, we found that BCL2L11, an apoptotic activator, was the direct target of miR-9-5p, miR-124-3p, and miR-132-3p. Engineered expression of miR-9-5p, miR-124-3p, or miR-132-3p significantly regulated proliferation and apoptosis in Tsc2 −/− cells. Manipulated expression of BCL2L11 also led to proliferation and apoptosis alterations in Tsc2 −/− cells, in agreement with the effects of the above three miRNAs. In addition, BCL2L11 rescued the proliferation and apoptotic inhibition induced by miR-9-5p, miR-124-3p, and miR-132-3p in Tsc2
Introduction
Tuberous sclerosis complex (TSC) is an autosomaldominant genetic disorder that results from a mutation in either the TSC1 or TSC2 gene [1] . The TSC1 and TSC2 gene products, hamartin and tuberin, respectively, form a protein complex that suppresses the mammalian target of the rapamycin (mTOR) pathway, which is a critical regulator of cell growth and proliferation [2, 3] . TSC is characterized by hamartomatous lesions in many organs, and up to 80% of patients with TSC develop renal angiomyolipomas (TSCAMLs), which are composed of dysplastic blood vessels, smooth muscle-like cells, and adipose tissue [4] . Genetic analyses have shown that these different cell types within an individual AML are clonal, indicating that they must be derived from a neoplastic stem cell that has the capacity to differentiate into these different lineages [5, 6] . The latest evidence suggests that the neoplastic stem cell of renal AMLs should be renal epithelial cell [7] . The incidence of renal angiomyolipoma increases with age, and most patients develop multiple bilateral lesions that pose a significant tumor burden on the kidneys. Although they are mostly benign, TSC-AMLs can lead to a variety of complications, the most significant of which is rupture, causing renal hemorrhage and shock. Renin-dependent hypertension is also prevalent among TSC patients, and~15% of TSC patients develop end-stage renal disease. TSC-AML is a leading cause of TSC-related death in adult patients [4] .
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Therefore, fully elucidating the underlying mechanism of TSC-AML progression is critical and will be aided by a better understanding of its molecular genetic controls.
MicroRNAs (miRNAs) belong to a class of conserved endogenous non-coding small RNAs that posttranscriptionally regulate many genes and most cell processes [8] . Mature miRNAs are derived from pre-miRNA precursors composed of hundreds or thousands of nucleotides constituting monocistronic or polycistronic transcriptional units, and they anneal to complementary sites in the 3′ untranslated region (3′ UTR) of target transcripts, resulting in either transcript degradation or inhibition of protein translation [9] . A previous study provided supportive evidence that inflammation-related miRNAs specifically involved in the modulation of the interleukin (IL)-1R/ Toll-like receptor (TLR) pathway play a role in TSC cortical tubers [10] . Dombkowski et al. [11] showed that a set of four miRNAs (miR-23a, miR-34a, miR-34b, and miR-532-5p) were coordinately overexpressed in epileptogenic tubers compared with adjacent non-tuber tissue and confirmed that the TSC1 3′ UTR was targeted by miR-23a and miR-34a. However, little is known about the involvement of miRNAs in TSC-AML, and no reports on their role in TSC-AML have been published to date.
The integration of mRNA and miRNA microarrays could provide a more comprehensive understanding of the regulatory mechanisms governing TSC-AML. We therefore analyzed the miRNA expression profiles together with gene expression profiles in TSC-AML tissue compared with matched normal adjacent tissues for the same populations. The integrated analysis of miRNA and mRNA expression data can help provide insight into the regulatory mechanisms governing TSC-AML.
Materials and methods

Patients and tissue specimens
This study protocol was approved by the Human Ethics Committee at Peking Union Medical College Hospital. The procedures for the collection and use of tissues were performed in accordance with the ethical standards set forth in the Declaration of Helsinki. Tissue was snap frozen in liquid nitrogen and stored at −80 ℃ until used for RNA isolation or protein extraction. Tumor tissues and matched normal adjacent tissues without hemorrhages or necrosis were selected by the same pathologist. Typical tissue for miRNA and mRNA array is shown in Figure S1 . Multiple sections from the same tumor were combined to compensate for tumor heterogeneity. To identify the miRNA and mRNA signatures of TSC-AML, we determined the expression profiles of a cohort of four TSC-AML patients, designated the discovery set. A second cohort of six patients, designated the validation set, was recruited to validate the roles of specific miRNAs and mRNAs. Table S1 shows all of the patient demographics as well as the mutation types of the TSC patients. Figure S2 provides a flow chart outlining the bioinformatic analysis.
Cell culture and cell transfection
HEK-293T cells were obtained from the American Type Culture Collection. The Tsc2 −/− MEF cell line, which has been described previously, was a gift from Hongbing Zhang (Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China) [12, 13] . All cell lines were cultured in DMEM supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 mg/ml of streptomycin at 37°C in a humidified 5% CO 2 atmosphere. HEK-293T or Tsc2 −/− MEF cells were seeded in 6-well plates, and transfection was conducted after 24 h. The BCL2L11-overexpressing lentivirus and the control lentivirus were purchased from GenePharma (Shanghai, China); 10 6 recombinant lentivirus-transducing units and 5 mg/ml polybrene (Sigma, USA) were added to each well with gentle mixing to infect the HEK-293T or Tsc2 −/− MEF cells. Cell transfection with miR-24 mimics and inhibitors were conducted using Lipofectamine RNAiMAX (Invitrogen, USA) according to the manufacturer's instructions. For each well, equal doses (100 pmol) of miRNA mimics, inhibitors, siRNAs, or scrambled/negative control RNA were used. All RNA oligoribonucleotides were obtained from GenePharma (Shanghai, China).
Total RNA isolation (including miRNA)
Total RNA was isolated using TRIzol (Invitrogen, USA) and purified with an RNeasy mini kit (Qiagen, Germany) according to the manufacturer's instructions. RNA quality and quantity were assessed using a Nanodrop spectrophotometer (ND-1000, Nanodrop Technologies), and RNA integrity was determined by gel electrophoresis. All of the RNA samples were of good quality (260/280 nm absorbance ratios: 1.9~2.1). Each RNA sample was then divided into three aliquots, which were used for the miRNA microarray, the gene expression microarray, and real-time quantitative PCR.
miRNA and gene expression analysis
A miRCURY™ Hy3™/Hy5™ Power labeling kit (Exiqon, Denmark) was used for miRNA labeling according to the manufacturer's guidelines. Microarray analysis for miRNA profiling was conducted by Shanghai Kangcheng Technology using the miRCURY TM LNA Array system (v.18.0) according to the array manual (Exiqon, Denmark). Reverse transcription for first strand of cDNA was synthesized using an Invitrogen Superscript ds-cDNA synthesis kit (Invitrogen, USA). The ds-cDNA samples were labeled according to the manufacturer's instructions (Shanghai Kangcheng Technology, China). The Human 12 × 135K Gene Expression Array was manufactured by Roche NimbleGen. The miRNA and gene expression microarray raw data were normalized using quantile normalization and the robust multichip average (RMA) algorithm included in the NimbleScan software. The signal values were log 2 transformed, and then the quantile and percentile shifts were applied to obtain equal distributions of the probe signal intensities. Comparative analysis between the samples from the TSC-AML and matched normal adjacent tissue groups was carried out using t tests (p values) and Benjamini-Hochberg false discovery rate (FDR) corrections (adjusted p values). The expression levels of genes and miRNAs were compared with those of the reference RNA and were determined to be differentially expressed if the adjusted p values were <0.05 and if the fold change (FC) was >2.0.
Real-time quantitative PCR analysis
Real-time quantitative PCR was performed using the miScript PCR System with 10× miScript Primer Assays for miRNAs (Qiagen, Germany) to confirm the array results. The U6 snRNA primer assay (Qiagen, Germany) was chosen as an endogenous reference for normalization, and all procedures were carried out according to the manufacturer's recommendations. To validate the different expression levels of the mRNAs determined by microarray, qPCR primers were selectively designed for 10 mRNAs that were found to be differentially expressed in the discovery screen; GAPDH was selected as the internal control. These primers are described in Table S2 . Reverse transcription for first strand cDNAs was performed using an Invitrogen Superscript ds-cDNA synthesis kit (Invitrogen, USA). Melting curve analysis and agarose gel electrophoresis were used to assess the specificity of the qPCR products.
Gene ontology (GO) and kyoto encyclopedia of genes and genomes (KEGG) pathway analyses GO and KEGG pathway analyses were performed using Cytoscape V2.8 (http://cytoscape.org/) with the ClueGO V1.3 plug-in. ClueGO determines the distribution of the target gene list across the GO terms and pathways. The p values were calculated using right-sided hypergeometric tests, and Benjamini-Hochberg adjustments were used for multiple test correction. An adjusted p value <0.05 indicated a statistically significant deviation from the expected distribution, and thus the corresponding GO terms and pathways were enriched in target genes. We analyzed all of the differentially expressed genes using GO and KEGG pathway analyses.
miRNA-mRNA enrichment and negative correlation analyses
Putative target gene sets of differentially expressed miRNAs were predicted using the following algorithms: miRBase (http://www.mirbase.org/), Miranda (http://www. microrna.org/), and TargetScan14 (http://www.targetscan. org/). The p values were calculated using right-sided hypergeometric tests, and Benjamini-Hochberg adjustments were used for multiple test correction. An adjusted p value <0.05 indicated a statistically significant deviation from the expected distribution. Pearson correlation coefficients between a particular miRNA and its predicted target mRNAs were computed using R (http://www.R-project.org) to determine whether the expression levels of each miRNA and of its mRNA targets were negatively correlated. The miRNA-mRNA interaction network was constructed using Cytoscape software.
Luciferase reporter assay
For dual luciferase assays, luciferase reporter pMIR-REPORT vectors (Promega, USA) containing the 3′ UTR of BCL2L11 with its wild-binding site (WT) or with mutant-binding sites (MUT) were specifically synthesized (GenePharma, China). HEK-293T cells were transfected with 10 ng of each pMIR-REPORT construct along with miRNA mimics/inhibitors or scrambled/negative controls and Lipofectamine 2000 reagent (Invitrogen, USA). After 48 h, the cells were lysed, and the firefly and Renilla luciferase activities were measured using the dual-luciferase reporter assay system (Promega, USA). Each fragment containing a putative miRNA-binding site was cloned into the pMIR-REPORT vector immediately downstream of the Renilla luciferase gene. The results are presented as the ratio of Renilla luciferase activity to firefly luciferase activity.
Western blot analysis
Frozen tissue was homogenized with a mortar and a pestle for each sample. Liquid nitrogen was added into the mortar during homogenization to keep the tissue frozen. Cold 1× cell lysis buffer with protease inhibitor cocktail was added to the frozen tissue powder, mixed and scooped into a 2 ml eppendorf tube. Then, the protein extract was centrifuged for 10 min at 14,000 × g in a cold centrifuge. Supernatant was transferred into a fresh 1.5 ml eppendorf tube and smaller aliquots of each protein extract were stored at −80°C
. Total protein concentration was determined with the BioRad Protein Assay Dye Reagent Concentrate (Bio-Rad, USA). Protein samples were separated on 10% SDS-PAGE gels, transferred to polyvinylidene fluoride (PVDF) membranes, and probed with goat polyclonal antibodies to BCL2L11 (Santa Cruz Biotechnology, USA) or GAPDH (Cell Signaling Technology, USA) overnight at 4°C. After extensive washing, the membranes were incubated with secondary antibody conjugated to horseradish peroxidase (Cell Signaling Technology, USA) for 1 h at room temperature. Blots were developed using the enhanced chemiluminescence (ECL) system (PE Life Science, USA). The optical intensity of each stained protein band was determined using Quantity One software.
Cell proliferation analysis
Cell proliferation assays were conducted using a Cell Counting Kit-8 (CCK-8, Dojindo Laboratories, Japan) according to the manufacturer's instructions. The cells were seeded in 96-well plates at~5000 cells per well and cultured in growth medium. Ten microliters of CCK-8 were added to 90 μl of culture medium at the indicated time. Subsequently, the cells were incubated at 37°C for 2 h, and the optical density was measured at 450 nm.
Apoptosis analysis
Apoptosis was evaluated via annexin V and 7-AAD binding assays using a PE Annexin V Apoptosis Detection Kit I (BD 
Statistical analysis
All statistical analyses were performed with SPSS 19.0 software (SPSS, Chicago, IL, USA). Data are expressed as the mean ± standard deviation (M ± SD) from three separate experiments. Statistical significance was determined by paired or unpaired Student's t tests for the standardized expression data. p < 0.05 was considered statistically significant.
Results
Discovery and validation of differentially expressed genes and miRNAs
After applying a stringent filtering approach that compared TSC-AML samples with matched normal adjacent tissue (adjusted p value <0.05, fold change >2.0), we identified 691 upregulated and 1973 downregulated genes (Table S3 ) and 8 upregulated and 7 downregulated miRNAs (Table S4) . Figure 1a shows a heat map of the expression profiles of the top 40 most variable mRNAs generated by cluster analysis. Figure 1b shows a heat map of 15 differentially expressed miRNAs generated by cluster analysis. These results indicate that gene expression in TSC-AMLs can be robustly different from that in matched normal adjacent tissue. Subsets of mRNAs (ten upregulated genes and ten downregulated genes) and miRNAs (five upregulated miRNAs and five downregulated miRNAs) that were identified to be differentially expressed by microarray analysis were selected for further validation in both the discovery set and the validation set. Comparison of the expression levels between the microarray data and the qPCR results demonstrated a strong correlation between the two platforms (Figs. 1c, d and S3) . The fold changes in the expression levels of the tested mRNAs and miRNAs determined using qPCR were largely concordant with the microarray data.
GO and KEGG enrichment of differentially expressed genes
Four hundred fifty-four GO biological processes (p values <0.05) were associated with the downregulated genes. As shown in Fig. 2a , the top 10 significantly enriched biological processes were as follows: multicellular organismal process, single-multicellular organism process, response to stimulus, cell communication, signaling, single-organism signaling, Gprotein-coupled receptor signaling pathway, cell-cell signaling, sensory perception of chemical stimulus, and sensory perception. Five hundred seventy-five GO biological processes (p values <0.05) were associated with the upregulated genes. As shown in Fig. 2e , the top 10 significantly enriched biological processes were as follows: organelle organization, cellular component organization, cellular component organization or biogenesis, negative regulation of biological process, cellular metabolic process, cell cycle, nucleobasecontaining compound metabolic process, negative regulation of cellular process, heterocycle metabolic process, and intracellular signal transduction.
Eighty GO cellular components (p values <0.05) were associated with the downregulated genes. As shown in Fig. 2b , the top 10 significantly enriched cellular components were as follows: plasma membrane, cell periphery, plasma membrane part, intrinsic component of plasma membrane, membrane part, integral component of plasma membrane, intrinsic component of membrane, integral component of membrane, extracellular space and membrane. Sixty-five GO cellular components (p values <0.05) were associated with the upregulated genes. As shown in Fig. 2f , the top 10 significantly enriched cellular components were as follows: plasma membrane, cell periphery, plasma membrane part, intrinsic component of plasma membrane, membrane part, integral component of plasma membrane, intrinsic component of membrane, integral component of membrane, extracellular space and membrane.
One hundred and three GO molecular functions (p values <0.05) were associated with the downregulated genes. As shown in Fig. 2c , the top 10 significantly enriched molecular functions were as follows: receptor activity, signaling receptor activity, signal transducer activity, molecular transducer activity, transmembrane signaling receptor activity, G-protein-coupled receptor activity, substratespecific channel activity, channel activity, passive transmembrane transporter activity, and cation channel activity. One hundred and two GO molecular functions (p values <0.05) were associated with the upregulated genes. As Twenty-three KEGG pathways (p values <0.05) were associated with the downregulated genes. As shown in Fig. 2d , the top 10 significantly enriched biological processes were as follows: olfactory transduction, graft-versushost disease, neuroactive ligand-receptor interaction, natural killer cell-mediated cytotoxicity, antigen processing and presentation, intestinal immune network for IgA production, Staphylococcus aureus infection, calcium signaling pathway, autoimmune thyroid disease, and hematopoietic cell lineage. Thirty-two KEGG pathways (p values <0.05) were associated with the upregulated genes. As shown in Fig. 2h , the top 10 significantly enriched pathways were as follows: oxytocin signaling pathway, cGMP-PKG signaling pathway, endocytosis, RNA transport, dopaminergic synapse, ubiquitin-mediated proteolysis, sphingolipid signaling pathway, adrenergic signaling in cardiomyocytes, circadian rhythm, and platelet activation.
Global miRNA-regulated network integration
To further explore the relationship between miRNA and TSC-AML progression, we utilized the online target gene prediction software programs miRBase, Miranda, and TargetScan to predict the target mRNAs of the identified miRNAs. The integrated analysis of miRNAs and mRNA expression levels is based on the assumption that increased or decreased expression of a specific miRNA results in, at least partially, decreased or increased expression of corresponding target mRNAs. Therefore, we investigated the existence of any inverse correlation between the up-or downregulated expression of an miRNA and its predicted targets ( Figure S4) , and a total of 5202 functional miRNA-mRNA pairs were connected by eight highly dysregulated miRNAs (Fig. 3a) . Twenty-five GO biological processes (p values <0.05) were associated with these dysregulated mRNAs. As shown in Fig. 3b , the top six significantly enriched biological processes were as follows: single-organism signaling, cellular process, regulation of cellular process, biological regulation, regulation of biological process, and single-organism cellular process. Twenty-six KEGG pathways (p values <0.05) were associated with the dysregulated genes. As shown in Fig. 3c , KEGG pathway enrichment analysis showed a network of six highly enriched miRNA pathways. The top ten significantly enriched pathways included the PI3K-Akt signaling pathway, pathways in cancer, Ras signaling pathway, calcium signaling pathway, Rap1 signaling pathway, dopaminergic synapse, adrenergic signaling in cardiomyocytes, oxytocin signaling pathway, cGMP-PKG signaling pathway, and ubiquitin-mediated proteolysis.
Targeting of the BCL2L11 3′ UTR by miR-9-5p, miR-124-3p, and miR-132-3p
Each miRNA has many target mRNAs; a single mRNA can also be regulated by more than one miRNA. BCL2L11, an apoptotic activator, stood out as an attractive candidate, and its 3′ UTR contains putative recognition sites that could bind to miR-9-5p, miR-124-3p, and miR-132-3p, indicating the possible role of these three miRNAs in modulating BCL2L11 (Fig. 4a) . The expression of the BCL2L11 protein was clearly decreased in TSC-AML tissues compared with matched normal adjacent tissue, suggesting that BCL2L11 expression may be involved in the progression of TSC-AML (Fig. 4b) . To verify whether BCL2L11 is the target of miR-9-5p, miR-124-3p, and miR-132-3p, we constructed 3′ UTR luciferase reporters with WT BCL2L11 containing each of the potential three miRNA recognition elements individually as well as corresponding 3′ UTR mutants. A construct with Renilla luciferase only acted as a control. The results showed that HEK-293T cells cotransfected with miR-9-5p, miR-124-3p, and miR-132-3p mimics or inhibitors with the WT BCL2L11 reporter displayed decreased or increased luciferase activities, respectively, compared with the control groups, whereas the luciferase activity of the mutant BCL2L11 reporter significantly changed (Fig. 4c, e) . Furthermore, western blotting showed that miR-9-5p, miR-124-3p, and miR-132-3p mimics downregulated the expression of miR-9-5p, miR-124-3p, and miR-132-3p, while miR-9-5p, miR-124-3p, and miR-132-3p inhibitors upregulated the expression of miR-9-5p, miR-124-3p, and miR-132-3p (Fig. 4d, f) . These results indicated that miR-9-5p, miR-124-3p, and miR-132-3p can directly regulate BCL2L11. miR-9-5p, miR-124-3p, and miR-132-3p regulate cell proliferation and apoptosis in Tsc2 −/− cells
To explore whether and how miR-9-5p, miR-124-3p, and miR-132-3p regulate cell proliferation and apoptosis in Fig. 4 Targeting of the BCL2L11 3′ UTR by miR-9-5p, miR-124-3p, and miR-132-3p. 
Tsc2
−/− cells, we overexpressed these three miRNAs in Tsc2 −/− cells. CCK-8 assays showed that Tsc2 −/− cells transfected with miR-9-5p, miR-124-3p, or miR-132-3p mimics showed increased cell proliferation (Fig. 5a ). In addition, the overexpression of miR-9-5p, miR-124-3p, or miR-132-3p markedly decreased the percentage of apoptotic cells when compared with cells transfected using the negative control (Fig. 5c, d ). Conversely, knockdown of miR-9-5p, miR-124-3p, or miR-132-3p inhibited cell proliferation (Fig. 5b) . Moreover, downregulation of miR-9-5p, miR-124-3p, or miR-132-3p markedly increased the percentage of apoptotic cells when compared with cells transfected using the scrambled control (Fig. 5e, f) . Taken together, these results indicate that miR-9-5p, miR-124-3p, and miR-132-3p are involved in the regulation of cell proliferation and apoptosis in Tsc2 −/− cells. showed increased cell proliferation; in contrast, transfection with a lentivirus overexpressing BCL2L11 had the opposite effect on cell proliferation (Fig. 6d) . In addition, transfecting Tsc2 −/− cells with BCL2L11 siRNA markedly decreased the percentage of apoptotic cells when compared with cells transfected using control siRNA, whereas transfecting Tsc2 −/− cells with a lentivirus overexpressing BCL2L11 increased cell apoptosis (Fig. 6e, f) . Taken together, our results suggest that BCL2L11 is crucial for the proliferation and apoptosis of Tsc2 −/− cells.
BCL2L11 rescues the effects of miR-9-5p, miR-124-3p, and miR-132-3p related to the regulation of proliferation and apoptosis in Tsc2 −/− cells
To provide further evidence that miR-9-5p, miR-124-3p, and miR-132-3p are involved in the regulation of proliferation and apoptosis in TSC-AML, we used lentivirus particles and miR-9-5p, miR-124-3p, or miR-132-3p mimics to overexpress BCL2L11 in Tsc2 −/− cells simultaneously. As shown in Fig. 7a , b, co-transfection of miR-9-5p, miR-124-3p, or miR-132-3p mimics and BCL2L11 lentivirus particles rescued BCL2L11 expression compared with single transfections of miR-9-5p, miR-124-3p, or miR-132-3p mimics (Fig. 4d) . Moreover, overexpression of BCL2L11 in Tsc2 −/− cells rescued the cellular proliferation (Fig. 7c ) and apoptosis inhibition (Fig. 7d) induced by these three miRNAs compared with the single transfection of miR-9-5p, miR-124-3p, or miR-132-3p mimics (Fig. 4a, c) . Taken together, our results suggest that miR-9-5p, miR-124-3p, or miR-132-3p might promote proliferation and inhibit apoptosis in Tsc2 −/− cells by silencing BCL2L11.
Discussion
Through microarray profiling, we identified 15 miRNAs and 2664 mRNAs that were differentially expressed in TSC-AML tissues compared to matched normal adjacent tissues. We selected and confirmed the expression of a number of these miRNAs and mRNAs using real-time PCR in samples from both the discovery and validation groups. The expression of these miRNAs and the global profiles of the mRNAs was integrated, and the findings showed that the BCL2L11 gene identified in our mRNA microarray data showed a high level of association with miR-9-5p, miR-124-3p, and miR-132-3p, which might contribute to TSC-AML by promoting proliferation and inhibiting apoptosis. We used a luciferase reporter assay to demonstrate targeting of the BCL2L11 3′ UTR by miR-9-5p, miR-124-3p, and miR-132-3p. Engineered expression of miR-9-5p, miR-124-3p, or miR-132-3p significantly regulated proliferation and apoptosis in Tsc2 −/− cells. Manipulated expression of BCL2L11 in Tsc2 −/− cells also led to alterations in proliferation and apoptosis, in agreement with the effects of above three miRNAs. In addition, BCL2L11 rescued the cell proliferation and apoptosis inhibition promoted by miR-9-5p, miR-124-3p, and miR-132-3p in Tsc2 −/− cells. These studies reveal the importance of BCL2L11 targeting by miR-9-5p, miR-124-3p, and miR-132-3p as a novel regulatory network in TSC-AML. BCL2L11 is a member of the BCL-2 family that is located in the outer membrane of mitochondria, where it acts as an important regulator, mediating excitotoxic apoptosis, apoptosis-inducing factor translocation, and mitochondrial depolarization [14, 15] . BCL2L11 has been shown to be critical for apoptosis in B and T lymphocytes, macrophages, and granulocytes [16] . In addition to neutralizing anti-apoptotic proteins, BCL2L11 promotes apoptosis by binding to Bax, which causes a conformational change in Bax that leads to its activation [17] . The antiapoptotic BCL2 members have multiple domains, while the pro-apoptotic members of the BCL2 family, including BCL2L11, are BH3-domain-only proteins [18, 19] . While the role of BCL2L11 in these biological processes has been reported, its role in TSC-AML remains unknown, emphasizing the urgent need to fully elucidate the mechanisms that govern BCL2L11 regulation.
MiRNAs have emerged as mediators of gene expression [20] . They direct the regulation of cellular processes including differentiation, proliferation, cell-cell interaction, cell death, metabolism, and many diseases. Previous studies have provided supportive evidence that miRNAs play a role in TSC cortical tubers [10, 11] ; however, the role of miRNAs in the kidneys of TSC patients has not previously been investigated. Another important aim of this study was to determine the possible regulatory role of miRNAs in TSC-AML. Several potential-binding sites were observed in the 2664 dysregulated genes and 15 dysregulated miRNAs in TSC-AML tissues identified by bioinformatic prediction. miR-9-5p, miR-124-3p, and miR-132-3p were predicted to target the 3′ UTR of BCL2L11 in the miRNA-mRNA network. miR-9-5p is broadly conserved in animals and was first identified as a crucial regulator for the development and maturation of the nervous system as well as in tumors outside the nervous system [21, 22] . A previous study demonstrated that miR-9-5p could specifically regulate the translation of BCL2L11 and induce increased expression of BCL2L11 in ischemic stroke, which then leads to neuronal apoptosis [23] . miR-124-3p is the most abundant miRNA in the brain, and it is involved in stem cell regulation and neurodevelopment [24, 25] . miR-132-3p has been shown to play an important role in synaptic transmission, inflammation, angiogenesis, and even cancer [26] [27] [28] . In endothelial cells, angiogenic factors, such as VEGF and bFGF, can promote the transcription of miR-132-3p, which further silences p120RasGAP expression and prevents its active conformation to induce proliferation [26] . In this study, we found that overexpressing miR-9-5p, miR-124-3p, and miR-132-3p promoted proliferation and inhibited apoptosis in Tsc2
−/− cells and that BCL2L11 reduction mimicked miR-9-5p, miR-124-3p, and miR-132-3p induction. Interestingly, we observed that the restoration of BCL2L11 expression successfully attenuated the pro-proliferative and anti-apoptotic effects of miR-9-5p, miR-124-3p, and miR-132-3p on Tsc2 −/− cells. These results suggest that the targeting of BCL2L11 is a major mechanism by which miR-9-5p, miR-124-3p, and miR-132-3p exert their tumorpromoting functions. Therefore, the modulation of BCL2L11 by miR-9-5p, miR-124-3p, and miR-132-3p might at least partially explain why the upregulation of these miRNAs in TSC-AML can promote cell proliferation and inhibit cell apoptosis in Tsc2 −/− cells.
To investigate how these signature miRNAs really participate in the gene alteration of TSC-AML in depth, we performed bioinformatic analyses. GO analysis is widely recognized as a leading tool for the organization and functional annotation of molecular attributes [29] . For greater insight into the data, we also performed signal pathway analysis using the KEGG pathway mapping tool, which is based on gene ontology classifications. The GO and KEGG pathway analyses of the commonly dysregulated genes also provided us with substantial information about the development and progression of TSC-AML. The GO analysis revealed that single-organism signaling, cellular process, regulation of cellular process, biological regulation, regulation of biological process, and singleorganism cellular process were among the most prominent biological processes, while PI3K-Akt signaling pathway, pathways in cancer, Ras signaling pathway, calcium signaling pathway, Rap1 signaling pathway, dopaminergic synapse, adrenergic signaling in cardiomyocytes, oxytocin signaling pathway, cGMP-PKG signaling pathway, and ubiquitin-mediated proteolysis were significantly represented in the KEGG pathway analysis. In addition, our result also showed that mTOR signing pathway plays an important role in the development of TSC-AML and provided more data for clinical use of mTOR inhibitors. Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, has demonstrated its significant reduction in renal angiomyolipoma volume compared with placebo in the phase 3 EXIST-2 trial [30] . Consensus guideline has recommended as the first-line therapy for TSC-AML [31] .
In conclusion, this study, to the best of our knowledge, represents the first integrated analysis of miRNA and mRNA expression to explore epigenetic factors in TSC-AML. We identified a number of miRNAs that are differentially expressed in TSC-AML tissues. Furthermore, we reported the altered expression of miRNA processing genes in TSC-AML tissue compared with matched normal adjacent tissue. Renal AML contain an admixture of clonal tumor cells with features of several different mesenchymal lineages, Filipa et al. [7] showed that the renal AML neoplastic stem cells arising from renal epithelial cells. Therefore, it is reasonable for us to use the matched normal renal tissue as the control of TSC-AML. Finally, we constructed a post-transcriptional regulatory network of miRNA-target cells. Therefore, we propose that miR-9-5p, miR-124-3p, and miR-132-3p, along with their target BCL2L11, may be suitable targets for molecular therapeutic approaches for TSC-AML. −/− cells with BCL2L11 lentivirus and miR-9-5p, miR-124-3p, or miR-132-3p mimics or the scrambled control. d Tsc2 −/− cells were cotransfected with BCL2L11 lentivirus and miR-9-5p, miR-124-3p, or miR-132-3p mimics or the scrambled control. Apoptosis profiles were analyzed by flow cytometry
